Drug & medication recalls

Asclemed USA Inc. dba Enovachem Pharmaceuticals recalls Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Eno…

Recall date
March 19, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0330-2021
FDA classification
Class III
Brand / firm
Asclemed USA Inc. dba Enovachem Pharmaceuticals
Sold / distributed
Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.

Why it was recalled

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608

Get recall alerts

Free email alert whenever Asclemed USA Inc. dba Enovachem Pharmaceuticals has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Asclemed USA Inc. dba Enovachem Pharmaceuticals